We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
-8.78%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$455M
AUM Growth
-$47.9M
Cap. Flow
-$460K
Cap. Flow %
-0.1%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LRMR icon
Larimar Therapeutics
LRMR
+$460K

Sector Composition

Rank Sector Weight
1 Communication Services 50.24%
2 Consumer Discretionary 49.49%
3 Healthcare 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
1
DraftKings
DKNG
$11.4B
$225M 49.49%
5,894,409
– –
IAS
2
DELISTED
Integral Ad Science
IAS
$221M 48.58%
22,722,770
– –
SNAP icon
3
Snap
SNAP
$7.32B
$4.08M 0.9%
245,559
– –
ROKU icon
4
Roku
ROKU
$21.1B
$3.46M 0.76%
57,707
– –
LRMR icon
5
Larimar Therapeutics
LRMR
$416M
$1.25M 0.27%
172,184
-60,000
-26% -$460K

Similar funds

RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SO
Sierra Ocean Ripon, California $122M AUM 16.19% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Atlas Venture Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Atlas Venture Advisors held 5 positions worth $455M, down 9.5% from $503M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. Atlas Venture Advisors opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 50% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Atlas Venture Advisors's biggest Q2 2024 reduction was Larimar Therapeutics, cutting an estimated $460K.
  • Atlas Venture Advisors's ten largest holdings make up 100% of its $455M portfolio in Q2 2024.
  • Atlas Venture Advisors opened 0 new positions and closed 0 in Q2 2024.
  • Atlas Venture Advisors's portfolio value fell 9.5% quarter-over-quarter to $455M.

Based on Atlas Venture Advisors's 13F filing for Q2 2024, filed 5 Aug 2024.